TTrialPathMatch Me to Trials
← Back to trials
RecruitingLower Respiratory Tract Infection

The Impact of MeMed BV® on Management of Patients With Suspected Lower Respiratory Tract Infections (LRTI) in the Emergency Department (ED) and Urgent Care Center (UCC) ("JUPITER" TRIAL)

Eligible age

18–99 yrs

Accepts

All genders

Locations

7 states

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

This is a Prospective, multi-center study enrolling adults subjects presented to the ED/Urgent care, with symptoms consistent with lower respiratory infection (LRTI). The reason of this study is to demonstrate the MeMed BV can help clinicians make decisions about using antibiotics in patients with lower respiratory track infections and see how it would impact clinical outcomes, antibiotics use, hospitalizations, ED clinicians find ways to improve health and medical care.

Sponsor: MeMed Diagnostics Ltd.

You may qualify if…

  • ✓ Patients eligible for inclusion are required to fulfill all of the following criteria:
  • ✓ Written informed consent must be obtained from the patient or his/her legal guardian.
  • ✓ 18 years of age or older.
  • ✓ Current disease duration ≤ 7 days.
  • ✓ Tactile fever or measured temperature ≥ 37.8°C (100°F) (any body site, any measurement device, including self-reported), either of them noted at least once within the last 7 days.
  • ✓ Clinical suspicion of bacterial or viral LRTI: At least one of the following respiratory signs or symptoms: cough (new or worsening), sputum production, dyspnea/shortness of breath, auscultatory abnormality (e.g. wheezing, rhonchi).
  • ✓ Clinician intent to prescribe antibiotics based on the currently available data.

You may not qualify if…

  • ✕ Patients fulfilling any of the following criteria are not eligible for inclusion in the infectious cohort:
  • ✕ Systemic antibiotics within 72 hours prior to enrollment
  • ✕ Inflammatory disease (e.g., IBD, SLE, Rheumatoid arthritis, Kawasaki, other vasculitis)
  • ✕ Congenital immune deficiency (CID)
  • ✕ A proven or suspected infection on presentation with Mycobacterial (e.g., MAC, MABC), parasitic or fungal (e.g., Candida, Histoplasma, Aspergillus) pathogen
  • ✕ HIV, HBV, or HCV infection (self-declared or known from medical records)
  • ✕ Major surgery, trauma and\\or burns in the last 7 days
  • ✕ Pregnancy- self reported or medically confirmed

Where it's recruiting

Florida

Jacksonville

Kansas

Kansas City

New York

Brooklyn · Stony Brook

Pennsylvania

Philadelphia

South Carolina

Charleston

Texas

Dallas

Wisconsin

Milwaukee

Source: ClinicalTrials.gov · NCT05762302 · last updated 2026-01-21

The Impact of MeMed BV® on Management of Patients With Suspected Lower · TrialPath